SMRT depleted breast cancer cell line response to estradiol: time course
Analysis of ER-alpha+ MCF7 breast cancer cells depleted for the silencing mediator of retinoic acid and thyroid hormone receptor (SMRT). SMRT depleted cells examined 4 and 24 hours following treatment with estradiol. Results provide insight into the role of SMRT in breast cancer progression.
Cancer Type: Breast Cancer
GPL: 6244
Number of Genes with Data: 928
Number Observations: 24
Number Outputs: 1
Imbalanced Ratio: 1
Default Task: Classification